Jinhai Medical Technology (HKG:2225) booked SG$17.1 million in attributable loss for 2025, narrowing from SG$18.0 million in 2024, according to a Hong Kong bourse filing Friday.
Shares of the healthcare and construction outsourcing firm fell over 12% in morning trade Monday.
Loss per share was SG$0.0033, compared with SG$0.0035 in the prior year.
Revenue fell to SG$46.3 million from SG$50.2 million in 2024.